| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | B1MW2ME77A |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C20H23F6N7O3 |
| Molecular Weight | 523.44 |
| AlogP | 2.15 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 116.34 |
| Molecular species | None |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 36.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 3130 | - | - | - | |
|
Enzyme
Transferase
|
- | 3-8 | 0.22-0.22 | - | - | |
|
Transcription factor
|
- | - | - | - | 100 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650508 |
| FDA SRS | B1MW2ME77A |
CONTENTS